John Letaw
Papers
1
Total Citations
13
H-Index
1
About
John Letaw is a researcher whose work bridges clinical genomics and public health, with a focus on the early detection of inherited disease risk. His major contributions center on population-based genetic screening, demonstrating how large-scale testing can uncover hidden carriers of cancer predisposition and familial hypercholesterolemia. His landmark 2023 study, "Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon," has already garnered 13 citations, highlighting its influence in shaping real-world screening programs. By analyzing genomic data from a diverse, unselected population, Letaw’s work provides critical evidence that universal screening can identify at-risk individuals who would otherwise be missed by family-history-based approaches. This research has significant implications for preventive medicine, potentially reducing the burden of preventable cancers and heart disease. Letaw’s contributions are notable for their translational impact, moving genomics from the clinic into community health. His work stands as a model for integrating genetic risk assessment into routine public health practice, making him a key voice in the evolving landscape of precision medicine and population health.
Research Focus
Key Achievements
Top Papers
- 1